TIDMEVG 
 
ABERFORTH PARTNERS LLP 
 
Disclosure under Rule 2.11 of the City Code on Takeovers and Mergers 
 
Aberforth Partners LLP ("Aberforth") provided a non-binding letter of intent to 
Investec plc regarding Investec's plc's proposed acquisition of Evolution Group 
plc ("Evolution"), as referred to in the announcement of the Recommended Share 
Offer dated 9 September 2011. On 15 September 2011, Aberforth disposed of 
464,300 shares (over which it had voting authority) in Evolution, on behalf of 
clients. As a result, Aberforth now intends to vote in favour of the 
resolutions to be proposed at the Court Meeting and the Evolution general 
meeting necessary to approve the Scheme (or as the case may be, to accept the 
Takeover Offer) in respect of 15,333,344 Evolution shares, over which it has 
voting authority. 
 
Aberforth Partners LLP 
 
16 September 2011 
 
 
 
END
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Evgen Pharma
Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Evgen Pharma